Cargando…
Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
Although the incidence and mortality of SARS-CoV-2 infection has been declining during the pandemic, the problem related to designing novel antiviral drugs that could effectively resist viruses in the future remains relevant. As part of our continued search for chemical compounds that are capable of...
Autores principales: | Baev, Dmitry S., Blokhin, Mikhail E., Chirkova, Varvara Yu., Belenkaya, Svetlana V., Luzina, Olga A., Yarovaya, Olga I., Salakhutdinov, Nariman F., Shcherbakov, Dmitry N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822074/ https://www.ncbi.nlm.nih.gov/pubmed/36615498 http://dx.doi.org/10.3390/molecules28010303 |
Ejemplares similares
-
Design and Evaluation of Bispidine-Based SARS-CoV-2
Main Protease Inhibitors
por: Shcherbakov, Dmitriy, et al.
Publicado: (2021) -
Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus
por: Dalinger, A. I., et al.
Publicado: (2023) -
Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
por: Belenkaya, Svetlana V., et al.
Publicado: (2023) -
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
por: Belenkaya, Svetlana V., et al.
Publicado: (2023) -
(+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
por: Filimonov, Aleksandr S., et al.
Publicado: (2022)